Although 6 million potential donors are registered worldwide, finding a donor compatible for allogeneic stern cell graft is hard because of HLA polymorphism. MADO (Marrow Donors) aims at evaluating optimisation of Registries in Europe by increasing the proportion of donors with rare HLA types to reduce inequality of patients in a cost/effective way. The main concept is an evolving filter to screen potential donors at low cost before full HLA typing for the likely presence of frequent types, using new markers and techniques. Organisational scenarios will then be designed. MADO involves 9 WP over 2 years and 12 partners in EU countries: 4 European Registries, sociologists, economists, public health unit, immunogenetics/molecular laboratories, bioinformatics, industry.
Call for proposalData not available
Funding SchemeCSC - Cost-sharing contracts
2300 RC Leiden
2333 ZA Leiden
NW3 2QG London